Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells.
about
Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitroDrugging topoisomerases: lessons and challengesAdvances in using PARP inhibitors to treat cancerImmunodetection of human topoisomerase I-DNA covalent complexesGenome-wide transcriptional effects of the anti-cancer agent camptothecinPhase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyDynamic regulation of Rad51 by E2F1 and p53 in prostate cancer cells upon drug-induced DNA damage under hypoxiaRationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition.Drugging the Cancers Addicted to DNA Repair.Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform.Biochemical assays for the discovery of TDP1 inhibitorsGlioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibitionTrapping of PARP1 and PARP2 by Clinical PARP Inhibitors.Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives.DNA ligase III acts as a DNA strand break sensor in the cellular orchestration of DNA strand break repairTyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitorsProtein expression of DNA damage repair proteins dictates response to topoisomerase and PARP inhibitors in triple-negative breast cancer.Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomasThe DNA repair endonuclease Mus81 facilitates fast DNA replication in the absence of exogenous damageRemoval of reactive oxygen species-induced 3'-blocked ends by XPF-ERCC1.Repair synthesis step involving ERCC1-XPF participates in DNA repair of the Top1-DNA damage complex.Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes.Pyrimidine Pool Disequilibrium Induced by a Cytidine Deaminase Deficiency Inhibits PARP-1 Activity, Leading to the Under Replication of DNA.Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damagePhosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assayIsolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA.Lasonolide A, a potent and reversible inducer of chromosome condensation.DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions.Inhibition of Poly(ADP-Ribose) Polymerase Enhances Radiochemosensitivity in Cancers Proficient in DNA Double-Strand Break RepairThe Arf/p53 protein module, which induces apoptosis, down-regulates histone H2AX to allow normal cells to survive in the presence of anti-cancer drugs.Replication-dependent irreversible topoisomerase 1 poisoning is responsible for FdUMP[10] anti-leukemic activityPhase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888) in Combination with Irinotecan in Patients with Advanced Solid TumorsTDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs.SbcCD-mediated processing of covalent gyrase-DNA complex in Escherichia coli.Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro.Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panelDifferential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.C-terminal region of activation-induced cytidine deaminase (AID) is required for efficient class switch recombination and gene conversion
P2860
Q24615499-E651D44B-BFA7-4C00-8A23-81593DF61917Q27000099-E9C2F54F-7CFA-4B41-B795-EBAD10AE292EQ27003972-0E57CC09-3A55-439A-B65F-CD086F730DD8Q27324108-00A6FA19-F43A-4D6E-82C6-EC1DFA301309Q28534613-964E43D3-B3D3-4C5F-A1B5-5F1642EBBD42Q33409117-14D3CFD5-5F8E-4401-953F-C720E7EA42E3Q33584594-F9C5BA60-6221-4458-AABB-F1A7975E8637Q33603605-AF00DD3A-3162-4B16-A292-BD5FCB0F8ABAQ33702497-E49FE980-97BB-441C-82A5-3B19838D6581Q33875792-C3E8C29C-CEAE-4F0E-B2CD-BA081DFFC05EQ34017010-64BFF3F7-8503-46B8-9E8F-F255CD95232FQ34021070-57AD6865-04E8-4C75-A01D-3925B04BA663Q34034221-6161CFEA-3D26-4586-B3D0-43BB681F5F4DQ34309488-681F5726-3DE6-4305-850F-2DB39EE449CBQ34614630-A1A89766-4ADA-4A59-96C8-D51D9BA7D4CDQ35097944-63451938-F433-4452-8A4E-AB7232046677Q35167579-0B430C41-4FB3-4396-826D-ED6C30EC4FECQ35182345-A72ACA0D-9D5D-41CB-9110-9386213A669CQ35195304-5B80B197-4852-4583-989A-1D8FD5FEFD41Q35456778-5109F62D-7219-4371-91F1-6B9CB5BFA0F6Q35566661-0C6A6ADC-B9AA-4C9E-B705-7164756B1E1FQ35646857-E847FE4B-7DD5-47E1-AD80-87C5CB7E5250Q35670720-B5E04A4D-235B-4484-86C8-EE4495B4D53FQ35693354-C3F827AF-F466-4F04-BF72-303A648270F9Q35763155-C3763EF6-AA0D-43F6-9D44-1D6F02B08AF9Q35884399-7E4AEF5D-68CB-4EFD-8105-2E03303A66E9Q36270038-BF630C43-C04E-4375-9578-CCB3D3F61484Q36364221-58564DDC-3CFF-48EC-8BBC-FAEB94BB012FQ36556339-48B877AE-8AB6-4B06-95ED-8B17D9E06EB2Q36588889-4595FC5D-4838-47C3-BA12-090791871CC0Q36656132-C1CDC49C-2DA4-4859-AC9E-299DDA98F99BQ36832574-85E88F75-4376-4CB3-B37E-00A87CFC6D79Q36862902-A2576FD0-7B34-4D32-B410-2D96C269FD8FQ37059846-F41A6012-88FC-478F-B298-29E8B5E5DCABQ37148469-7D32D296-87AD-4097-AA60-9254D4922CBFQ37263853-D75D7113-7E2E-425B-9DCF-367769CDA921Q37401119-87BC377C-864E-4A59-89C7-B2B01C5A4223Q37572609-4A80076E-50A5-4FC6-BBDB-96ACD88F20AEQ37574005-5973C25A-95FE-409B-B2A3-0E074F692C43Q37587676-477DEF2E-9CC8-4A32-9CC3-DF7D50024668
P2860
Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Poly(ADP-ribose) polymerase an ...... DNA damage in mammalian cells.
@ast
Poly(ADP-ribose) polymerase an ...... DNA damage in mammalian cells.
@en
type
label
Poly(ADP-ribose) polymerase an ...... DNA damage in mammalian cells.
@ast
Poly(ADP-ribose) polymerase an ...... DNA damage in mammalian cells.
@en
prefLabel
Poly(ADP-ribose) polymerase an ...... DNA damage in mammalian cells.
@ast
Poly(ADP-ribose) polymerase an ...... DNA damage in mammalian cells.
@en
P2093
P2860
P356
P1476
Poly(ADP-ribose) polymerase an ...... DNA damage in mammalian cells.
@en
P2093
James H Doroshow
Jennifer A Seiler
Keli K Agama
Marie Regairaz
Yong-Wei Zhang
P2860
P304
P356
10.1093/NAR/GKQ1304
P407
P50
P577
2011-01-11T00:00:00Z